Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease

INTRODUCTION: Recurrence of gastrointestinal stromal tumors (GISTs) after surgical resection and imatinib mesylate (IM) adjuvant therapy poses a significant treatment challenge. We present the case of a patient who underwent surgical resection after recurrence and review the current literature regar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol Med
Autors principals: Platoff, Rebecca M., Morano, William F., Marconcini, Luiz, DeLeo, Nicholas, Mapow, Beth L., Styler, Michael, Bowne, Wilbur B.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733166/
https://ncbi.nlm.nih.gov/pubmed/29333308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8349090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars